# Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)

> **NCT00663403** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 8 (actual)

## Conditions studied

- Critically Ill
- Hemodialysis

## Interventions

- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT00663403
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663403, "Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00663403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*